Introduksjon

Denne siden gir en grundig analyse av den kjente historikken for insidernes handelsaktiviteter for Michael Halstead. Insidere er ledere, direktører eller betydelige investorer i et selskap. Det er ulovlig for insidere å gjøre handler i deres selskaper basert på spesifikke, ikke-offentlig informasjon. Dette betyr ikke at det er ulovlig for dem å gjøre noen handler i deres egne selskaper. Imidlertid må de rapportere alle handler til SEC via et skjema 4. Til tross for disse begrensningene, antyder akademisk forskning at insidere - generelt sett - har en tendens til å overgå markedet i sine egne selskaper.

Gjennomsnittlig handelslønnsomhet

Den gjennomsnittlige handelslønnsomheten er den gjennomsnittlige avkastningen av alle åpne markedskjøp gjort av insideren de siste tre årene. For å beregne dette, undersøker vi hvert eneste åpne marked, uplanlagte kjøp som er gjort av insideren, men dette inkluderer ikke alle handler som ble markert som en del av en 10b5-1 handelsplan. Vi beregner deretter gjennomsnittlig ytelse av disse handlene over 3, 6 og 12 måneder, gjennomsnittlig hver av disse varighetene for å generere en endelig ytelsesmåling for hver handel. Til slutt,

Dersom lønnsomheten for denne interne handelen er "N/A", har enten den interne personen ikke gjort noen åpen-markeds kjøp de siste tre årene, eller så er handlene for nylig til å beregne en pålitelig prestasjonsmåler.

Oppdateringsfrekvens: Daglig

Se listen over de mest lønnsomme insidetraderne.

Selskaper med rapporterte insiderposisjoner

SEC-arkiveringene indikerer at Michael Halstead har rapporterte beholdninger av handler i følgende selskaper:

Verdipapir Navn Siste rapporterte høydepunkter
US:ITCI / Intra-Cellular Therapies, Inc. President 0
Senior V.P., Corp. Development 0
Hvordan tolke diagrammene

De følgende diagrammene viser aksjens ytelse etter hver åpen markedstransaksjon som ikke var planlagt, utført av Michael Halstead. Ikke-planlagte handler er handler som ikke ble gjort som en del av en 10b5-1 handelsplan. Aksjeytelsen er kartlagt som kumulativ prosentendring i aksjekursen. For eksempel, hvis en innsidehandel ble gjort 1. januar 2019, vil diagrammet vise daglig prosentendring for verdipapiret til dagens dato. Dersom aksjeprisen går fra $10 til $15 i løpet av denne tiden, vil den kumulative prosentendringen i aksjeprisen være 50%. En endring i prisen fra $10 til $20 vil være 100%, og en endring i prisen fra $10 til $5 vil være - 50%.

Til syvende og sist er målet vårt å avgjøre hvor tett insidernes handler korrelerer med overavkastninger (positiv eller negativ) i aksjekursen for å se om insidere timer sine handler for å tjene på intern informasjon. Se for deg en situasjon der en insider gjør dette. I denne situasjonen, forventer vi enten (a) positive avkastninger etter kjøp, eller (b) negative avkastninger etter salg. I tilfelle (a) KJØP-diagrammet ville vise en serie av oppadgående kurver, som indikerer positive avkastninger etter hver kjøpstransaksjon. I tilfelle (b) ville SALG-diagrammet vise en serie av nedadgående kurver, som indikerer negative avkastninger etter hver salgstransaksjon.

Imidlertid er dette alene ikke nok til å dra konklusjoner. Hvis, for eksempel, aksjeprisen for selskapet steg jevnt over mange år uten å følge en syklisk trend, ville vi forventet at alle postkjøpsdiagrammer skal ha en stigende trend. På samme måte vil ikke-sykliske nedganger over mange år resultere i nedadgående trend i post-trade diagrammer. Ingen av disse diagrammene ville antyde aktiviteter som insidertrening.

Den sterkeste indikatoren ville vært en situasjon der aksjekursen var ekstremt syklisk, og det var både positive signaler i KJØPSdiagrammet og negative plot i SALGSdiagrammet. Denne situasjonen ville vært sterkt antydende om en insider som timet handler til sin økonomiske fordel.

Innsidernes handelshistorikk

Tabellen viser den komplette listen over innsidehandler gjort av Michael Halstead som avslørt til Securies Exchange Comission (SEC).

Fildato Transaksjonsdato Skjema Ticker Verdipapir Kode 10b5-1 Aksjer Gjenværende aksjer Prosent
endring
Aksje
pris
Transaksjons
verdi
Gjenværende
verdi
2025-04-02 2025-04-02 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
D - Sale to Issuer −21 307 0 −100,00 132,00 −2 812 524
2025-03-10 2025-03-10 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
F - Taxes −3 757 21 307 −14,99 131,24 −493 069 2 796 331
2025-03-10 2025-03-10 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
M - Exercise 7 345 25 064 41,45
2025-03-10 2025-03-06 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
F - Taxes −6 718 17 719 −27,49 131,19 −881 334 2 324 556
2025-03-10 2025-03-06 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
M - Exercise 13 133 24 437 116,18
2025-03-04 2025-03-01 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
F - Taxes −6 261 11 304 −35,64 128,20 −802 660 1 449 173
2025-03-04 2025-03-01 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
M - Exercise 12 239 17 565 229,80
2025-02-04 2025-01-31 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
F - Taxes −5 691 5 326 −51,66 127,00 −722 757 676 402
2025-02-04 2025-01-31 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
A - Award 11 017 11 017
2024-11-14 2024-11-13 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale X −5 343 0 −100,00 88,92 −475 100
2024-11-14 2024-11-13 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale X −13 371 5 343 −71,45 88,17 −1 178 921 471 092
2024-11-14 2024-11-13 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
M - Exercise 18 714 18 714 36,89 690 359 690 359
2024-11-14 2024-11-12 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale X −1 648 0 −100,00 90,89 −149 787
2024-11-14 2024-11-12 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale X −6 116 1 648 −78,77 89,63 −548 177 147 710
2024-11-14 2024-11-12 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale X −15 105 7 764 −66,05 88,72 −1 340 116 688 822
2024-11-14 2024-11-12 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
M - Exercise 22 869 22 869 23,94 547 484 547 484
2024-03-11 2024-03-11 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale X −1 238 0 −100,00 66,70 −82 575
2024-03-11 2024-03-11 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale X −6 107 1 238 −83,14 65,82 −401 963 81 485
2024-03-11 2024-03-10 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
M - Exercise 7 345 7 345
2024-03-11 2024-03-07 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale X −220 0 −100,00 66,81 −14 698
2024-03-11 2024-03-07 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale X −12 912 220 −98,32 66,14 −854 000 14 551
2024-03-08 2024-03-06 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
M - Exercise 13 132 13 132
2024-02-27 2024-02-26 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale X −392 0 −100,00 70,13 −27 491
2024-02-27 2024-02-26 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale X −7 215 392 −94,85 69,54 −501 731 27 260
2024-02-27 2024-02-26 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale X −300 7 607 −3,79 68,54 −20 562 521 384
2024-02-27 2024-02-23 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
M - Exercise 7 907 7 907
2024-02-05 2024-02-02 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale X −714 0 −100,00 67,17 −47 959
2024-02-05 2024-02-02 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale X −11 146 714 −93,98 66,37 −739 760 47 388
2024-02-05 2024-02-01 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
A - Award 11 860 11 860
2024-01-12 2024-01-11 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale X −1 486 0 −100,00 67,80 −100 751
2024-01-12 2024-01-11 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale X −30 360 1 486 −95,33 67,10 −2 037 156 99 711
2024-01-12 2024-01-11 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale X −18 154 31 846 −36,31 66,31 −1 203 792 2 111 708
2024-01-12 2024-01-11 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
M - Exercise 3 885 50 000 8,42 23,94 93 007 1 197 000
2024-01-12 2024-01-11 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
M - Exercise 46 115 46 115 12,73 587 044 587 044
2023-11-14 2023-11-13 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale X −41 067 0 −100,00 54,01 −2 218 029
2023-11-14 2023-11-13 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale X −8 933 41 067 −17,87 53,37 −476 754 2 191 746
2023-11-14 2023-11-13 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
M - Exercise 34 836 50 000 229,73 12,73 443 462 636 500
2023-11-14 2023-11-13 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
M - Exercise 15 164 15 164 15,47 234 587 234 587
2023-03-13 2023-03-13 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale X −476 0 −100,00 44,15 −21 015
2023-03-13 2023-03-13 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale X −6 868 476 −93,52 44,99 −308 991 21 415
2023-03-13 2023-03-10 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
M - Exercise 7 344 7 344
2023-03-13 2023-03-10 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale X −2 500 0 −100,00 42,52 −106 300
2023-03-13 2023-03-10 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale X −14 208 2 500 −85,04 43,20 −613 786 108 000
2023-03-13 2023-03-09 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
A - Award 16 708 16 708
2023-02-27 2023-02-24 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale X −7 906 0 −100,00 47,03 −371 819
2023-02-27 2023-02-23 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
M - Exercise 7 906 7 906
2023-02-22 2023-02-21 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale X −100 0 −100,00 49,60 −4 960
2023-02-22 2023-02-21 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale X −1 100 100 −91,67 48,68 −53 548 4 868
2023-02-22 2023-02-21 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale X −643 1 200 −34,89 47,23 −30 369 56 676
2023-02-22 2023-02-21 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale X −9 296 1 843 −83,45 46,56 −432 822 85 810
2023-02-22 2023-02-18 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
M - Exercise 11 139 11 139
2022-12-02 2022-12-01 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale X −22 796 0 −100,00 53,48 −1 219 130
2022-12-02 2022-12-01 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale X −27 204 22 796 −54,41 53,94 −1 467 384 1 229 616
2022-12-02 2022-12-01 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
M - Exercise 50 000 50 000 15,47 773 500 773 500
2022-03-14 2022-03-10 4 ITCI Intra-Cellular Therapies, Inc.
Restricted Stock Units
A - Award 22 034 22 034
2022-03-14 2022-03-10 4 ITCI Intra-Cellular Therapies, Inc.
Stock Option (right to buy)
A - Award 17 916 17 916
2022-02-25 2022-02-24 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale X −4 188 0 −100,00 51,62 −216 185
2022-02-25 2022-02-24 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale X −3 718 4 188 −47,03 52,38 −194 749 219 367
2022-02-25 2022-02-23 4 ITCI Intra-Cellular Therapies, Inc.
Restricted Stock Units
M - Exercise −7 906 15 813 −33,33
2022-02-25 2022-02-23 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
M - Exercise 7 906 7 906
2022-02-23 2022-02-22 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale X −4 550 0 −100,00 54,98 −250 159
2022-02-23 2022-02-22 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale X −6 589 4 550 −59,15 55,69 −366 941 253 390
2022-02-23 2022-02-18 4 ITCI Intra-Cellular Therapies, Inc.
Restricted Stock Units
M - Exercise −11 139 11 139 −50,00
2022-02-23 2022-02-18 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
M - Exercise 11 139 11 139
2022-01-11 2022-01-10 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale X −4 380 0 −100,00 40,12 −175 726
2022-01-11 2022-01-10 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale X −12 755 4 380 −74,44 40,81 −520 532 178 748
2022-01-11 2022-01-10 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale X −2 504 17 135 −12,75 41,74 −104 517 715 215
2022-01-11 2022-01-08 4 ITCI Intra-Cellular Therapies, Inc.
Restricted Stock Units
M - Exercise −19 639 0 −100,00
2022-01-11 2022-01-08 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
M - Exercise 19 639 19 639
2021-12-23 2021-12-21 4 ITCI Intra-Cellular Therapies, Inc.
Stock Option (right to buy)
M - Exercise −63 717 0 −100,00
2021-12-23 2021-12-21 4 ITCI Intra-Cellular Therapies, Inc.
Stock Option (right to buy)
M - Exercise −88 146 0 −100,00
2021-12-23 2021-12-21 4 ITCI Intra-Cellular Therapies, Inc.
Stock Option (right to buy)
M - Exercise −25 000 0 −100,00
2021-12-23 2021-12-21 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale X −4 344 0 −100,00 44,87 −194 915
2021-12-23 2021-12-21 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale X −8 690 4 344 −66,67 45,74 −397 481 198 695
2021-12-23 2021-12-21 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale X −36 434 13 034 −73,65 46,87 −1 707 662 610 904
2021-12-23 2021-12-21 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale X −104 775 49 468 −67,93 47,84 −5 012 436 2 366 549
2021-12-23 2021-12-21 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale X −22 620 154 243 −12,79 48,62 −1 099 784 7 499 295
2021-12-23 2021-12-21 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
M - Exercise 63 717 176 863 56,31 15,73 1 002 268 2 782 055
2021-12-23 2021-12-21 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
M - Exercise 88 146 113 146 352,58 17,57 1 548 725 1 987 975
2021-12-23 2021-12-21 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
M - Exercise 25 000 25 000 13,86 346 500 346 500
2021-02-25 2021-02-23 4 ITCI Intra-Cellular Therapies, Inc.
Restricted Stock Units
A - Award 23 719 23 719
2021-02-25 2021-02-23 4 ITCI Intra-Cellular Therapies, Inc.
Stock Option (right to buy)
A - Award 18 714 18 714
2021-02-22 2021-02-19 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale X −1 100 0 −100,00 38,91 −42 801
2021-02-22 2021-02-19 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale X −10 039 1 100 −90,12 39,28 −394 332 43 208
2021-02-22 2021-02-18 4 ITCI Intra-Cellular Therapies, Inc.
Restricted Stock Units
M - Exercise −11 139 22 278 −33,33
2021-02-22 2021-02-18 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
M - Exercise 11 139 11 139
2021-01-12 2021-01-11 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale X −1 936 0 −100,00 31,65 −61 274
2021-01-12 2021-01-11 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale X −17 702 1 936 −90,14 32,07 −567 703 62 088
2021-01-12 2021-01-08 4 ITCI Intra-Cellular Therapies, Inc.
Restricted Stock Units
M - Exercise −19 638 19 639 −50,00
2021-01-12 2021-01-08 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
M - Exercise 19 638 19 638
2021-01-05 2021-01-04 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale X −3 174 0 −100,00 30,94 −98 204
2021-01-05 2021-01-04 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale X −12 986 3 174 −80,36 31,39 −407 631 99 632
2021-01-05 2021-01-03 4 ITCI Intra-Cellular Therapies, Inc.
Restricted Stock Units
M - Exercise −16 160 0 −100,00
2021-01-05 2021-01-03 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
M - Exercise 16 160 16 160
2020-11-19 2020-11-17 4 ITCI Intra-Cellular Therapies, Inc.
Stock Option (right to buy)
M - Exercise −75 000 25 000 −75,00
2020-11-19 2020-11-17 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale −3 761 0 −100,00 27,95 −105 120
2020-11-19 2020-11-17 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale −75 664 3 761 −95,26 27,60 −2 088 326 103 804
2020-11-19 2020-11-17 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
M - Exercise 75 000 79 425 1 694,92 13,86 1 039 500 1 100 830
2020-02-20 2020-02-18 4 ITCI Intra-Cellular Therapies, Inc.
Restricted Stock Units
A - Award 33 417 33 417
2020-02-20 2020-02-18 4 ITCI Intra-Cellular Therapies, Inc.
Stock Option (right to buy)
A - Award 26 754 26 754
2020-01-28 2020-01-24 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
J - Other −3 809 4 425 −46,26 23,61 −89 930 104 474
2020-01-28 2020-01-24 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
A - Award 8 043 8 234 4 210,99
2020-01-10 2020-01-09 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale X −19 638 191 −99,04 26,16 −513 730 4 997
2020-01-08 2020-01-08 4 ITCI Intra-Cellular Therapies, Inc.
Restricted Stock Units
M - Exercise −19 638 39 277 −33,33
2020-01-08 2020-01-08 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
M - Exercise 19 638 19 829 10 281,68
2020-01-08 2020-01-06 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale X −17 513 191 −98,92 30,46 −533 446 5 818
2020-01-08 2020-01-06 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale X −3 945 17 704 −18,22 29,80 −117 561 527 579
2020-01-03 2020-01-03 4 ITCI Intra-Cellular Therapies, Inc.
Restricted Stock Units
M - Exercise −16 160 16 160 −50,00
2020-01-03 2020-01-03 4 ITCI Intra-Cellular Therapies, Inc.
Restricted Stock Units
M - Exercise −5 298 0 −100,00
2020-01-03 2020-01-03 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
M - Exercise 16 160 21 649 294,41
2020-01-03 2020-01-03 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
M - Exercise 5 298 5 489 2 773,82
2020-01-03 2020-01-02 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale X −25 191 −11,57 34,30 −858 6 551
2020-01-03 2020-01-02 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale X −1 200 216 −84,75 33,23 −39 876 7 178
2020-01-03 2020-01-02 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale X −4 959 1 416 −77,79 32,43 −160 820 45 921
2020-01-03 2020-01-02 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale X −1 623 6 375 −20,29 31,83 −51 660 202 916
2020-01-03 2019-12-31 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
A - Award 7 807 7 998 4 087,43
2019-01-08 2019-01-08 4 ITCI Intra-Cellular Therapies, Inc.
Restricted Stock Units
A - Award 58 915 58 915
2019-01-08 2019-01-08 4 ITCI Intra-Cellular Therapies, Inc.
Stock Option (right to buy)
A - Award 80 951 80 951
2019-01-08 2019-01-07 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale X −3 108 191 −94,21 12,42 −38 601 2 372
2019-01-08 2019-01-04 4 ITCI Intra-Cellular Therapies, Inc.
Restricted Stock Units
M - Exercise −3 108 0 −100,00
2019-01-08 2019-01-04 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale X −5 398 3 299 −62,07 11,80 −63 696 38 928
2019-01-08 2019-01-04 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale X −16 060 8 697 −64,87 11,34 −182 120 98 624
2019-01-08 2019-01-04 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
M - Exercise 3 108 24 757 14,36
2019-01-03 2019-01-03 4 ITCI Intra-Cellular Therapies, Inc.
Restricted Stock Units
M - Exercise −16 160 32 320 −33,33
2019-01-03 2019-01-03 4 ITCI Intra-Cellular Therapies, Inc.
Restricted Stock Units
M - Exercise −5 298 5 298 −50,00
2019-01-03 2019-01-03 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
M - Exercise 16 160 21 649 294,41
2019-01-03 2019-01-03 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
M - Exercise 5 298 5 489 2 773,82
2019-01-03 2019-01-02 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale X −7 807 191 −97,61 11,09 −86 580 2 118
2019-01-03 2018-12-31 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
A - Award 7 807 7 998 4 087,43
2018-01-24 2018-01-22 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale X −25 500 191 −99,26 18,03 −459 765 3 444
2018-01-05 2018-01-05 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale X −1 560 25 691 −5,72 17,49 −27 284 449 336
2018-01-05 2018-01-04 4 ITCI Intra-Cellular Therapies, Inc.
Restricted Stock Units
M - Exercise −3 108 3 108 −50,00
2018-01-05 2018-01-04 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale X −2 660 27 251 −8,89 15,75 −41 895 429 203
2018-01-05 2018-01-04 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
M - Exercise 3 108 29 911 11,60
2018-01-05 2018-01-03 4 ITCI Intra-Cellular Therapies, Inc.
Restricted Stock Units
A - Award 48 480 48 480
2018-01-05 2018-01-03 4 ITCI Intra-Cellular Therapies, Inc.
Stock Option (right to buy)
A - Award 65 164 65 164
2018-01-05 2018-01-03 4 ITCI Intra-Cellular Therapies, Inc.
Restricted Stock Units
M - Exercise −5 297 10 596 −33,33
2018-01-05 2018-01-03 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
M - Exercise 5 297 26 803 24,63
2017-01-09 2017-01-05 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale X −1 601 21 506 −6,93 16,55 −26 497 355 924
2017-01-05 2017-01-04 4 ITCI Intra-Cellular Therapies, Inc.
Restricted Stock Units
M - Exercise −3 107 6 216 −33,33
2017-01-05 2017-01-04 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
M - Exercise 3 107 23 107 15,54
2017-01-05 2017-01-03 4 ITCI Intra-Cellular Therapies, Inc.
Restricted Stock Units
A - Award 15 893 15 893
2017-01-05 2017-01-03 4 ITCI Intra-Cellular Therapies, Inc.
Stock Option (right to buy)
A - Award 63 717 63 717
2016-01-06 2016-01-04 4 ITCI Intra-Cellular Therapies, Inc.
Restricted Stock Units
A - Award 9 323 9 323
2016-01-06 2016-01-04 4 ITCI Intra-Cellular Therapies, Inc.
Stock Option (right to buy)
A - Award 39 307 39 307
2015-01-06 2015-01-02 4 ITCI Intra-Cellular Therapies, Inc.
Stock Option (right to buy)
A - Award 88 146 88 146
2014-11-06 2014-11-06 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
P - Purchase 13 000 20 000 185,71 15,47 201 110 309 400
2014-11-06 2014-11-05 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
P - Purchase 7 000 7 000 15,21 106 470 106 470
2014-07-31 2014-07-29 4 ITCI Intra-Cellular Therapies, Inc.
Stock Option (right to buy)
A - Award 100 000 100 000
2013-10-01 2013-10-01 4 WCRX Warner Chilcott plc
Ordinary shares, par value $0.01 per share
D - Sale to Issuer −36 370 0 −100,00
2013-10-01 2013-09-30 4 WCRX Warner Chilcott plc
Option to purchase ordinary shares par value $0.01 per share
D - Sale to Issuer −53 050 0 −100,00
2013-10-01 2013-09-30 4 WCRX Warner Chilcott plc
Option to purchase ordinary shares par value $0.01 per share
D - Sale to Issuer −26 050 0 −100,00
2013-10-01 2013-09-30 4 WCRX Warner Chilcott plc
Option to purchase ordinary shares par value $0.01 per share
D - Sale to Issuer −9 280 0 −100,00
2013-10-01 2013-09-30 4 WCRX Warner Chilcott plc
Option to purchase ordinary shares par value $0.01 per share
D - Sale to Issuer −10 340 0 −100,00
2013-10-01 2013-09-30 4 WCRX Warner Chilcott plc
Option to purchase ordinary shares par value $0.01 per share
D - Sale to Issuer −6 203 0 −100,00
2013-10-01 2013-09-30 4 WCRX Warner Chilcott plc
Option to purchase ordinary shares par value $0.01 per share
D - Sale to Issuer −1 463 0 −100,00
2013-10-01 2013-09-30 4 WCRX Warner Chilcott plc
Option to purchase ordinary shares par value $0.01 per share
D - Sale to Issuer −6 790 0 −100,00
2013-10-01 2013-09-30 4 WCRX Warner Chilcott plc
Option to purchase ordinary shares par value $0.01 per share
D - Sale to Issuer −1 945 0 −100,00
2013-10-01 2013-09-30 4 WCRX Warner Chilcott plc
Performance Restricted Share Units
D - Sale to Issuer −15 020 0 −100,00
2013-10-01 2013-09-30 4 WCRX Warner Chilcott plc
Ordinary shares, par value $0.01 per share
D - Sale to Issuer −15 470 36 370 −29,84
2013-07-02 2013-07-01 4 WCRX Warner Chilcott plc
Ordinary shares, par value $0.01 per share
S - Sale −366 51 840 −0,70 19,88 −7 276 1 030 579
2013-03-01 2013-02-28 4 WCRX Warner Chilcott plc
Ordinary shares, par value $0.01 per share
S - Sale −1 747 52 206 −3,24 13,46 −23 521 702 886
2013-02-21 2013-02-19 4 WCRX Warner Chilcott plc
Ordinary shares, par value $0.01 per share
S - Sale −419 53 953 −0,77 14,53 −6 087 783 813
2013-02-15 2013-02-13 4 WCRX Warner Chilcott plc
Option to purchase ordinary shares par value $0.01 per share
A - Award 53 050 53 050
2013-02-15 2013-02-13 4 WCRX Warner Chilcott plc
Performance Restricted Share Units
A - Award 15 020 15 020
2013-02-15 2013-02-13 4 WCRX Warner Chilcott plc
Ordinary shares, par value $0.01 per share
A - Award 15 470 54 372 39,77
2013-02-04 2013-02-01 4 WCRX Warner Chilcott plc
Ordinary shares, par value $0.01 per share
S - Sale −998 38 902 −2,50 14,18 −14 150 551 560
2013-01-31 2013-01-30 4 WCRX Warner Chilcott plc
Ordinary shares, par value $0.01 per share
S - Sale −320 39 900 −0,80 13,38 −4 283 534 026
2013-01-23 2013-01-22 4 WCRX Warner Chilcott plc
Ordinary shares, par value $0.01 per share
S - Sale −488 40 220 −1,20 13,50 −6 588 542 966
2012-10-01 2012-10-01 4 WCRX Warner Chilcott plc
Ordinary shares, par value $0.01 per share
S - Sale −77 40 708 −0,19 13,55 −1 043 551 593
2012-07-02 2012-07-02 4 WCRX Warner Chilcott plc
Ordinary shares, par value $0.01 per share
S - Sale −355 40 785 −0,86 17,96 −6 376 732 499
2012-03-02 2012-03-01 4 WCRX Warner Chilcott plc
Ordinary shares, par value $0.01 per share
S - Sale −725 41 140 −1,73 17,00 −12 324 699 347
2012-02-23 2012-02-21 4 WCRX Warner Chilcott plc
Ordinary shares, par value $0.01 per share
S - Sale −409 41 865 −0,97 16,82 −6 880 704 274
2012-02-02 2012-01-31 4 WCRX Warner Chilcott plc
Option to purchase ordinary shares par value $0.01 per share
A - Award 26 050 26 050
2012-02-02 2012-01-31 4 WCRX Warner Chilcott plc
Ordinary shares, par value $0.01 per share
A - Award 20 790 42 274 96,77
2012-01-31 2012-01-30 4 WCRX Warner Chilcott plc
Ordinary shares, par value $0.01 per share
S - Sale −320 21 484 −1,47 16,45 −5 265 353 448
2012-01-24 2012-01-23 4 WCRX Warner Chilcott plc
Ordinary shares, par value $0.01 per share
S - Sale −487 21 804 −2,18 17,32 −8 435 377 634
2012-01-12 2012-01-11 4 WCRX Warner Chilcott plc
Ordinary shares, par value $0.01 per share
S - Sale −452 22 291 −1,99 16,66 −7 531 371 379
P
Åpent marked eller private kjøp av ikke-derivat eller derivat sikkerhet.
S
Åpent marked eller private kjøp av ikke-derivat eller derivat sikkerhet.
A
Bevilgning, tildeling eller andre oppkjøp av verdipapirer fra selskapet (slik som en opsjon)
C
Konvertering av derivat
D
Salg eller overføring av verdipapirer tilbake til selskapet
F
Betaling av utøvelseskurs eller skatteplikt ved å bruke deler av verdipapirer mottat fra selskapet
G
Gave av verdipapirer fra eller til insidere
K
Aksjebytting og lignende sikringsavtaler
M
Øvelse eller konvertering av derivatverdipapir mottatt fra selskapet (for eksempel en opsjon)
V
En transaksjon frivilig rapportert på Skjema 4
J
Annet (med en fotnote som beskriver transaksjonen)